ArticleScientific reports2025
Network pharmacological prediction of chemical constituents and endophyte metabolites of medicinal plant Shengli grass.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endophyte function in climate-stressed crops: integrating molecular regulation, metabolic trade-offs, and ecological constraints.Plant signaling & behavior · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shengli grass has attracted growing attention in the fields of functional foods and medicines due to its widely reported healing effects, yet its chemical components and the potential mechanisms underlying its health benefits to humans remain insufficiently elucidated. This study employed headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS) to determine the volatile components (VOCs), extract components of Shengli Grass, and secondary metabolites of 11 endophytes isolated from it. Active components were screened, their biological targets identified via combined targeted fishing, and network-based analysis was conducted among active components, targets, enrichment pathways, and diseases to explore the potential molecular mechanisms of Shengli Grass in anti-inflammatory and antibacterial activities.A total of 100 VOCs, 51 extract components, and 24 endophyte secondary metabolites were identified. Olefins (e.g., selina-3,7(11)-diene, m-cymene) were the most abundant in Shengli Grass, followed by esters (e.g., linalyl propionate); endophyte secondary metabolites also had high ester content, with 29% of components overlapping with those of Shengli Grass. After screening via the TCMSP database, 110 chemical components (81 VOCs, 29 extract components) and 20 secondary metabolites were selected for network pharmacology, corresponding to 418 and 223 targets, respectively.Geranyl isobutyrate, neryl acetate, and neryl formate were proposed as the main anti-bacterial and anti-inflammatory components. GO function and KEGG pathway enrichment analyses of common targets revealed that Shengli Grass might exert its effects via pathways such as cancer, endocrine resistance, lipid and atherosclerosis, phosphorylation, xenobiotic stimulus response, calcium signaling, and protein phosphorylation; key targets included ALB, AKT1, EGFR, SRC, ESR1, and NFKB1.In conclusion, Shengli Grass exerts anti-inflammatory and antibacterial effects through multi-component, multi-target, and multi-pathway involvement in biological processes, providing a theoretical basis for its development and utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.